Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods
The goal of the federally recognized definition is to provide consistency in research and policy to address health concerns associated with these foods
Endocrine Society, July 12-15
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
GLP-1 receptor agonist use linked to lower risk for overall dementia, Alzheimer disease, nonvascular dementia compared with metformin
Similar Reduction Seen in Mortality for Exercise Patterns in Diabetes
Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs
Prevalence of Extremely Severe Obesity Increasing in Children
2008 to 2023 saw relative increase of 253.1 percent for extremely severe obesity, which is linked to higher odds of metabolic complications
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
Estimated risk ratio was lower with GLP-1 receptor agonists for those younger than 75 years, but was no different for those aged 75 years or older
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester
ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy
The EfficientNetB0 achieved more than 99 percent accuracy, with image processing speed <1 second per image
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio
